07:00 , Mar 24, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Ophthalmic disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Ophthalmic disease Glaucoma Complement component 1 q subcomponent A chain (C1QA); endothelin 2 (EDN2) Mouse studies suggest that antagonists of C1QA and...